Allogeneic Mouse Models of Graft-Versus-Host Disease
Ana Flávia Santos Linhares1, Barbara Maximino Rezende2, Marina Gomes Miranda Castor3
1Graduate Program in Biological Sciences: Physiology and Pharmacology, Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Methods in Molecular Biology (Clifton, N.J.)
|March 18, 2025
Summary
Graft-versus-host disease (GVHD) is a severe complication of hematopoietic cell transplantation. This chapter details mouse models for studying GVHD mechanisms and testing new therapies.
Area of Science:
- Immunology
- Transplantation Biology
- Preclinical Research
Background:
- Graft-versus-host disease (GVHD) is a life-threatening complication following allogeneic hematopoietic cell transplantation.
- GVHD involves the donor immune system attacking the recipient's tissues, impacting organs like skin, liver, and intestines.
- Understanding GVHD pathogenesis is vital for developing improved treatments and prevention strategies.
Purpose of the Study:
- To provide an overview of allogeneic and semi-allogeneic mouse models for GVHD research.
- To detail the methodology for inducing experimental GVHD in mice using a specific irradiation model.
- To highlight the importance of animal models in advancing GVHD knowledge and therapeutic development.
Main Methods:
- Overview of established allogeneic and semi-allogeneic mouse models for GVHD.
- Step-by-step protocol for inducing experimental GVHD in mice.
- Utilizing total body irradiation for myeloablation in the allogeneic mouse model.
Main Results:
- Experimental models facilitate the investigation of immune mechanisms underlying GVHD.
- These models are essential for evaluating the efficacy of novel therapeutic interventions.
- Insights gained from animal studies contribute to improving clinical outcomes for transplant recipients.
Conclusions:
- Animal models are indispensable tools for dissecting GVHD pathophysiology.
- Effective GVHD management relies on a thorough understanding derived from experimental models.
- Continued research using these models promises to enhance patient survival and quality of life post-transplant.


